雜志介紹

Advanced Therapeutics雜志介紹

《Advanced Therapeutics》是一本以English為(wei)(wei)(wei)主的(de)(de)未開(kai)放獲取國際(ji)優秀期(qi)刊(kan)(kan)，中(zhong)文名稱先進治(zhi)療學，本刊(kan)(kan)主要(yao)出(chu)版(ban)、報道醫學-PHARMACOLOGY & PHARMACY領(ling)域(yu)的(de)(de)研究動(dong)態(tai)以及在該(gai)(gai)領(ling)域(yu)取得的(de)(de)各方面的(de)(de)經驗(yan)和科研成(cheng)果，介紹該(gai)(gai)領(ling)域(yu)有關本專(zhuan)業(ye)的(de)(de)最(zui)新(xin)進展(zhan)，探討行(xing)業(ye)發(fa)(fa)展(zhan)的(de)(de)思路和方法，以促進學術信(xin)息交流，提高行(xing)業(ye)發(fa)(fa)展(zhan)。該(gai)(gai)刊(kan)(kan)已被(bei)國際(ji)權威數(shu)(shu)據庫SCIE收錄(lu)，為(wei)(wei)(wei)該(gai)(gai)領(ling)域(yu)相關學科的(de)(de)發(fa)(fa)展(zhan)起到了(le)良好的(de)(de)推動(dong)作用(yong)，也得到了(le)本專(zhuan)業(ye)人員的(de)(de)廣泛認(ren)可。該(gai)(gai)刊(kan)(kan)最(zui)新(xin)影響因子為(wei)(wei)(wei)3.7，最(zui)新(xin)CiteScore 指(zhi)數(shu)(shu)為(wei)(wei)(wei)7.1。

本刊近期中國(guo)學者發(fa)表的論文(wen)主(zhu)要有：

• TBX2-WNT3A Axis Mediates the Development of Colorectal Cancer In Vitro and In Vivo

  Author: Zhou, Yan; Dong, Mingjie; Li, Xiujuan

• Second Near-Infrared Light Triggered Mini Plasmonic Heterostructures for Photothermal-Derived Multimodal Synergistic Cancer Therapy

  Author: Xu, Zhourui; Aalinkeel, Ravikumar; Mahajan, Supriya D.; Rao, Nanxi; Chen, Ting; Jiang, Yihang; Yang, Chengbin; Xu, Gaixia; Schwartz, Stanley A.; Law, Wing-Cheung

• Enhanced Targeting, Retention, and Penetration of Amphotericin B Through a Biomimetic Strategy to Treat Against Vulvovaginal Candidiasis

  Author: Lin, Yijing; Yin, Qingqing; Zhuge, Deli; Hu, Yiqin; Yang, Xuewei; Tian, Dongyan; Li, Li; Wang, Haonan; Liu, Shuangshuang; Weng, Cuiye; Zhang, Xufei; Wen, Bin; Wang, Fang; Yan, Linzhi; Chen, Mengchun; Wang, Ledan; Chen, Yijie

• Multifunctional Alendronate-PEI Carbon Dots for the Treatment of Bone-Destructive Diseases via Bidirectional Regulation of Osteoblast-Osteoclast Function

  Author: Zhang, Kai; Da, Junlong; Wang, Jianqun; Liu, Lixue; Liu, Xinpeng; Yuan, Haoze; Jiang, Lili; Geng, Yawei; Liu, Xiaoyao; Jiang, Zhuling; Jin, Han; Li, Ying; Zhang, Bin

英文介紹

Advanced Therapeutics雜志英文介紹

Advanced Therapeutics provides a unique multidisciplinary forum for the best research in the next generation of therapeutics, such as targeted drug delivery, cellular and genetic therapies, personalized medicines and theranostics, as well as pharmacology, toxicology and drug discovery.Intended to provide a platform for researchers worldwide to exchange and share the latest research findings. As a professional journal dedicated to the field of therapeutic medicine, we are committed to promoting the development of medical scientific research, improving the treatment effectiveness of diseases, and contributing to human health and well-being.